These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9752894)

  • 21. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Antihypertensive Efficacy of the Triple Fixed Combination of Perindopril, Indapamide, and Amlodipine: The Results of the PETRA Study.
    Ábrahám G; Dézsi CA
    Adv Ther; 2017 Jul; 34(7):1753-1763. PubMed ID: 28646394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.
    Nádházi Z; Dézsi CA
    Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of an oral fixed low-dose perindopril 2 MG/indapamide 0.625 MG combination: a randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension.
    Castaigne A; Chalmers J; Morgan T; Chastang C; Feldmann L; Guez D
    Clin Exp Hypertens; 1999 Oct; 21(7):1097-110. PubMed ID: 10513830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure control and acceptability of perindopril and its fixed dose combinations with amlodipine or indapamide, in younger patients with hypertension.
    Bansal S; Chauhan DK; Ramesh D; Barmare S; Chakraborty S
    Indian Heart J; 2014; 66(6):635-9. PubMed ID: 25634398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients.
    Ghiadoni L; Magagna A; Kardasz I; Taddei S; Salvetti A
    Am J Hypertens; 2009 May; 22(5):506-12. PubMed ID: 19247267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a fixed low-dose perindopril/indapamide combination in essential hypertension. A randomised controlled study.
    Mallion JM; Chastang C; Unger P
    Clin Exp Hypertens; 2000 Jan; 22(1):23-32. PubMed ID: 10685722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: results of a double-blind multicenter study versus atenolol.
    Morgan TO; Louis WJ; MacDonald GJ; Conway EL; Bartholomeusz LC; Anderson AI; Cameron DP; Donnelly T; Frewin DB; Hooper MJ
    Am J Med; 1992 Apr; 92(4B):73S-78S. PubMed ID: 1580284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacotherapy with fixed low-dose combination of perindopril and the indapamide for arterial hypertension].
    Abasova LI; Hasanova ZA
    Lik Sprava; 2011; (5-6):51-4. PubMed ID: 22606892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
    de Leeuw PW; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Tolerability of Fixed-Dose Combination Perindopril/Indapamide in Hypertensive Patients with a History of Stroke or Transient Ischemic Attack: PICASSO Trial.
    Dézsi CA; Farsang C;
    Adv Ther; 2018 May; 35(5):644-654. PubMed ID: 29748913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a very-low-dose combination of perindopril and indapamide--preterax compared with cilazapril monotherapy in patients with inadequate blood pressure control--a randomized, double-blind, add-on study.
    Sung SH; Wu TC; Lin SJ; Chen JW
    J Chin Med Assoc; 2008 May; 71(5):247-53. PubMed ID: 18490229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
    Gosse P; Dubourg O; Guéret P; De Simone G; Schmieder R; De Leeuw PW; Degaute JP; García Puig J; Karpov Y; Magometschnigg D; Matos L; Amouyel P; Asmar R; Le Heuzey JY; Nieminen M; Dahlöf B
    J Hum Hypertens; 2002 Sep; 16(9):653-9. PubMed ID: 12214263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
    Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
    J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The FORTISSIMO program: advantages of fixed full dose combination of perindopril arginine and indapamide in the treatment of poorly controlled arterial hypertension].
    Karpov IuA
    Kardiologiia; 2013; 53(3):37-43. PubMed ID: 23548425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination perindopril/indapamide for the treatment of hypertension: a review.
    de Leeuw PW
    Expert Opin Pharmacother; 2011 Aug; 12(11):1827-33. PubMed ID: 21651456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.
    Gueyffier F; Subtil F; Bejan-Angoulvant T; Zerbib Y; Baguet JP; Boivin JM; Mercier A; Leftheriotis G; Gagnol JP; Fauvel JP; Giraud C; Bricca G; Maucort-Boulch D; Erpeldinger S;
    J Hum Hypertens; 2015 Jan; 29(1):22-7. PubMed ID: 24739801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
    Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
    J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.